Veradigm | MDRX - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Alcidion AUD 32K 9K 2025-12
Ambu A/S DKK 19M 4M 2026-03
Amplifon EUR 13.72M 921K 2025-12
Cardinal Health USD 101M 13M 2026-03
Centene USD 164M 4M 2026-03
Charles River Laboratories USD 26.74M 2.97M 2026-03
Cigna USD 153.27B 4.65B 2026-03
Coloplast 164M 0 2025-12
Computer Programs Systems USD 2.87M 911K 2025-12
CVS Health USD 774M 13M 2026-03
Diasorin EUR 5M 0 2026-03
Elevance Health USD 357M 9M 2026-03
General Electric Aerospace USD 496M 271M 2025-12
Gulf Medical Proj AED 33K 9K 2024-09
Humana USD 193M 47M 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Laboratory Of America USD 55.1M 100K 2026-03
Maximus USD 22.11M 1.3M 2026-03
McKesson USD 63M 11M 2025-12
Med Life RON 24.78M 2.15M 2023-12
Molina Healthcare USD 54M 2M 2026-03
Omnicell USD 431K 91K 2025-12
Oriola-kd EUR 2M 200K 2025-12
Owens Minor USD 27.93M 1.1M 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Rede D'or Sao Luiz BRL 1.5B 2.05B 2025-12
Siemens Healthineers EUR 100M 4M 2026-03
Sonova Holding CHF 24.2M 3.7M 2025-06
Supermax Corporation Bhd MYR 1.66M 1.44M 2025-09
UnitedHealth USD 955M 19M 2026-03
Veeva Systems USD 65.1M 8.4M 2025-03
Veradigm USD 1.25M 641K 2022-09
Xerox USD 31M 0 2024-12